Safety of sildenafil in infants

Authors

Samira Samiee-Zafarghandy, Children's National Medical Center
P. Brian Smith, Duke UniversityFollow
John N. van den Anker, George Washington UniversityFollow

Document Type

Response or Comment

Publication Date

5-2014

Journal

Pediatric Critical Care Medicine

Volume

Volume 15, Issue 4

Inclusive Pages

362-368

Keywords

Hypertension, Pulmonary--drug tehrapy; Phosphodiesterase 5 Inhibitors--administration & dosage; Phosphodiesterase 5 Inhibitors--adverse effects; Piperazines--administration & dosage; Piperazines--adverse effects; Sulfones--administration & dosage; Sulfones--adverse effects

Comments

Comment in

"Out of the blue"-safety and efficacy of pulmonary hypertension treatment in childhood*. [Pediatr Crit Care Med. 2014]

APA Citation

Samiee-Zafarghandy, S., Smith, P.B., Van den Anker, J.N. (2014). Safety of sildenafil in infants. Pediatric Critical Care Medicine, 15(4), 362-368.